Muscular Dystrophy A Concise Guide /

This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources.  New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care.  Also includ...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Huml, Raymond A. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03035nam a22004455i 4500
001 978-3-319-17362-7
003 DE-He213
005 20151204182117.0
007 cr nn 008mamaa
008 150716s2015 gw | s |||| 0|eng d
020 |a 9783319173627  |9 978-3-319-17362-7 
024 7 |a 10.1007/978-3-319-17362-7  |2 doi 
040 |d GrThAP 
050 4 |a RC346-429.2 
072 7 |a MJN  |2 bicssc 
072 7 |a MED056000  |2 bisacsh 
082 0 4 |a 616.8  |2 23 
245 1 0 |a Muscular Dystrophy  |h [electronic resource] :  |b A Concise Guide /  |c edited by Raymond A. Huml. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a XXIV, 191 p. 43 illus., 30 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a 1. Introduction to Muscular Dystrophy -- 2.Muscular Dystrophy: Historical Background and Types -- 3.FSHD: The Most Common Type of MD? -- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy -- 7.Overview of Current Treatments for Muscular Dystrophy -- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy -- 9.Orthopedic Care of Children with Muscular Dystrophy -- 10.Global Regulatory Landscape -- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy -- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy -- 13.US Patient Advocacy Groups -- 14.Global and National Patient Registries -- 15.Summary -- Index. 
520 |a This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources.  New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care.  Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances.  Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient. 
650 0 |a Medicine. 
650 0 |a Neurology. 
650 0 |a Pharmacotherapy. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Neurology. 
650 2 4 |a Pharmacotherapy. 
650 2 4 |a Medicine/Public Health, general. 
700 1 |a Huml, Raymond A.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319173610 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-17362-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)